Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 28 Show results per page	View Search Criteria \| Help With Results


1.		Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				21 and under				Other				BMT 0499 Solid NCT00179816

First Published: 7/18/2008


2.		Phase I/II Study of Anti-IGF-1R Recombinant Monoclonal Antibody IMC-A12 and Doxorubicin Hydrochloride in Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				16 and over				NCI				UCCRC-16227A 16227A, 8131, NCT00720174

Last Modified: 10/11/2007 First Published: 5/1/1999


3.		Phase II Study of Nonmyeloblative Allogeneic Peripheral Blood Stem Cell Transplantation and Donor Lymphocyte Infusions in Patients With Refractory Metastatic Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				10 to 80				NHLBI				NHLBI-99-H-0064 NCT00003839

Last Modified: 1/18/2008 First Published: 10/1/2002


4.		Phase II Pilot Study of Induction Chemotherapy Followed By Allogeneic/Syngeneic Peripheral Blood Stem Cell Transplantation in Patients With High-Risk, Recurrent Pediatric Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				4 to 35				NCI				NCI-02-C-0259H NCT00047372


5.		Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and under				Other				UMCC 9626 IRB 1996-195, NCT00141765


6.		Radiation Therapy to Treat Musculoskeletal Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				25 and under				Other				RTSARC NCT00186992


7.		External Beam Radiation With Intratumoral Injection Of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				Other				MCC-14497 NCT00365872


8.		A Pilot Study of Tumor Cell Vaccine for High-Risk Solid Tumor Patients Following Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				30 and under				Other				UMCC 2005.050 GCRC ID # 2191, NCT00405327

Last Modified: 8/16/2008 First Published: 3/2/2007


9.		Phase II Study of Intrathecal Iodine I 131 Monoclonal Antibody 3F8 in Patients With GD2-Expressing Central Nervous System or Leptomeningeal Neoplasms

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				Other				MSKCC-05122 NCT00445965

Last Modified: 5/22/2008 First Published: 5/4/2007


10.		Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				NCI				CINJ-3330 NCT00161187

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute